Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure

Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure

This work aimed to study the efficacy and safety of the class III antiarrhythmic agent cavutilide (Niferidil, Refralon) for pharmacological cardioversion in patients with paroxysmal and persistent atrial fibrillation (AF) and heart failure (HF). Methods and Results: In this retrospective cohort stud...

Full description

Bibliographic Details
Main Authors: Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Cardiovascular Development and Disease
Subjects:
heart failure
atrial fibrillation
rhythm control
cardioversion
antiarrhythmic drugs
Online Access:https://www.mdpi.com/2308-3425/10/12/487

Internet

https://www.mdpi.com/2308-3425/10/12/487

Similar Items